Ruth Halaban
Yale University
H-index: 73
North America-United States
Top articles of Ruth Halaban
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Interferon-stimulated neutrophils as a predictor of immunotherapy response | Cancer Cell | Madeleine Benguigui Tim J Cooper Prajakta Kalkar Sagie Schif-Zuck Ruth Halaban | 2024/2/12 |
Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction | medRxiv | Xinxing Li Tao Liu Antonella Bacchiocchi Mengxing Li Wen Cheng | 2024/1/13 |
Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma | Journal for Immunotherapy of Cancer | David G Su David A Schoenfeld Wael Ibrahim Raysa Cabrejo Dijana Djureinovic | 2024 |
A novel combination therapy targeting RAF, MEK and FAK to overcome skin cutaneous melanoma treatment resistance | Cancer Research | Simone Lubrano Farhoud Faraji Rodolfo Daniel Cervantes-Villagrana Sydney Ramirez Nadia Arang | 2024/3/22 |
Prospective analysis of pretreatment circulating CD4 memory T cell features associated with severe immunotherapy toxicity | Cancer Research | Abul Usmani Noah Earland Wubing Zhang Peter K Harris Antonietta Bacchiocchi | 2024/3/22 |
Circulating Tumor Reactive KIR+ CD8+ T cells Suppress Anti-Tumor Immunity in Patients with Melanoma | David Hafler Benjamin Lu Liliana Lucca Wesley Lewis Jiping Wang | 2024/2/28 | |
A subset of neutrophils as a predictive biomarker for immunotherapy response in patients with non–small-cell lung cancer and melanoma. | Yuval Shaked Madeleine Benguigui Ruth Halaban Antonella Bacchiocchi Iris Kamer | 2023/6/1 | |
Dynamic changes of circulating soluble PD-1/PD-L1 and its association with patient survival in immune checkpoint blockade-treated melanoma | International Immunopharmacology | Lingeng Lu Evan Risch Ruth Halaban Pinyi Zhen Antonella Bacchiocchi | 2023/5/1 |
Association between circulating CD4 memory T cell levels and severe immune-related adverse events in melanoma patients treated with immune checkpoint blockade | Cancer Research | Abul Usmani Noah Earland Wubing Zhang Peter K Harris Antonietta Bacchiocchi | 2023/4/4 |
Unannotated microprotein EMBOW regulates the interactome and chromatin and mitotic functions of WDR5 | Cell reports | Yanran Chen Haomiao Su Jianing Zhao Zhenkun Na Kevin Jiang | 2023/9/26 |
CD4 T cells and toxicity from immune checkpoint blockade | Noah Earland Wubing Zhang Abul Usmani Aishwarya Nene Antonella Bacchiocchi | 2023/9 | |
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma | Nature medicine | Alexander X Lozano Aadel A Chaudhuri Aishwarya Nene Antonietta Bacchiocchi Noah Earland | 2022/2 |
Rational combinations with the dual RAF/MEK inhibitor VS-6766 for treatment of cutaneous melanoma harboring BRAF, NRAS, NF1 or CRAF mutations | Cancer Research | Antonella Bacchiocchi Silvia Coma Sanjib Chowdhury Mario Sznol Ruth Halaban | 2022/6/15 |
Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11. 21 to metastasis | Nature communications | Farshad Farshidfar Kahn Rhrissorrakrai Chaya Levovitz Cong Peng James Knight | 2022/2/23 |
Retrospective cell lineage reconstruction in humans by using short tandem repeats | Cell reports methods | Liming Tao Ofir Raz Zipora Marx Manjusha S Ghosh Sandra Huber | 2021/7/26 |
21 Plasma-based proteomic profiling as a tool for predicting response to immunotherapy in melanoma patients | Michal Harel Coren Lahav Eyal Jacob Eran Issler Haim Bar | 2020/11/1 | |
Abstract PR01: Genomic UV-hypersensitive sites as sentinels for personal UV exposure | Cancer Prevention Research | Sanjay Premi Lynn Han Sameet Mehta James Knight Dejian Zhao | 2020/7/1 |
A proteomic biomarker discovery platform for predicting clinical benefit of immunotherapy in advanced melanoma. | Yuval Shaked Michal Harel Eran Issler Ella Fremder Eyal Jacob | 2020/5/20 |
Co-Authors
